News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
158 Results
Type
Article (4)
Press Release (154)
Section
Business (21)
Deals (1)
Drug Development (4)
News (32)
Policy (8)
Tag
Alliances (8)
Cancer (16)
Clinical research (9)
Collaboration (2)
Data (9)
Earnings (4)
Events (22)
Intellectual property (2)
IPO (1)
Legal (3)
Manufacturing (1)
Pancreatic cancer (6)
Patents (4)
People (11)
Phase 1 (9)
Pipeline (15)
Preclinical (4)
Regulatory (6)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (29)
2026 (25)
2025 (7)
2024 (5)
2023 (14)
2022 (29)
2021 (9)
2020 (11)
2019 (16)
2018 (12)
2017 (12)
2016 (16)
2015 (1)
2014 (1)
Location
Asia (19)
Australia (154)
Europe (1)
158 Results for "propanc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program
August 5, 2026
·
3 min read
Press Releases
Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027
September 9, 2026
·
4 min read
Press Releases
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
July 7, 2026
·
5 min read
Press Releases
Propanc Biopharma Initiates $5.0 Million Share Repurchase Program
July 2, 2026
·
3 min read
Press Releases
Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
July 21, 2026
·
5 min read
Press Releases
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
August 18, 2026
·
5 min read
Press Releases
Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program
June 11, 2026
·
4 min read
Press Releases
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
August 12, 2026
·
10 min read
Press Releases
Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
August 27, 2026
·
5 min read
Press Releases
Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
August 6, 2026
·
5 min read
1 of 16
Next
